Mitochondrial dysfunction is increasingly being recognized in many pathologies. Mitochondria, the power houses of cells have central roles to play in energy metabolism and apoptosis. Structure-Function studies designed towards characterizing and understanding defects in mitochondrial metabolism, dynamics and biogenesis in pathologies and response to treatments would provide insight into mitochondrial dysfunction. A 2-step imaging approach was used; (a) Zeiss 880/980 Airyscan Super Resolution microscopy to understand mitochondrial morphological response to treatment and (b) Fluorescence Lifetime Imaging (FLIM) -B&H TCSPC lifetime board coupled to a Zeiss 780 to track metabolic changes in HeLa cells by following the auto-fluorescent metabolic co-enzyme NAD(P)H. FLIM signatures, the lifetimes and the relative fractions of bound and free states of NAD(P)H and FAD are generated with multiphoton excitation by a pulsed femto-second infra-red laser. Publications suggest that FLIM multiphoton laser power requirements for NAD(P)H and FAD may not be well optimized, which could result in injurious effects to cells. We have characterized two photon (2p)- laser induced changes at the cellular level, particularly in mitochondria. Live-cell FLIM measurements were conducted on stage in HeLa cells by gradually increasing the laser average power, followed by the assessment of phototoxic effects. Our results show that NAD(P)H-a2%, the enzyme-bound fraction increases with rising laser average power, inducing cytotoxic damaging effects. As elevated NAD(P)H-a2% is also shown after drug treatment, sub-optimal laser power can be falsely interpreted as drug treatment response. Our study demonstrates how the laser power optimization at the specimen plane is critical in FLIM.
Fluorescence Lifetime Imaging Microscopy (FLIM) can be used to identify changes in metabolic activity during cancer progression and upon anti-cancer drug treatment. Prostate cancer (PCa) is one of the leading cancers in men in the USA. This research focusses on understanding the lifetime changes of endogenous biomarkers: NAD(P)H, FAD and Trp in LNCaP cells upon treatment with doxorubicin using our 3-channel FLIM approach. The LNCaP cells were treated with doxorubicin for 24hr. Images using FLIM of LNCaP control and treated cells were acquired on Zeiss 780 multiphoton confocal microscope coupled with B and H TCSPC FLIM board. After FLIM data fitting and processing we observed increase in the mean fluorescence lifetime of Trp, NAD(P)H and FAD with doxorubicin treatment. Additionally, we saw reduction in the NAD(P)H/FAD redox ratio with doxorubicin treatment. Our results identify the changes in the lifetime of these endogenous biomarkers and in the cellular redox state as a metabolic response with doxorubicin treatment in prostate cancer cells.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.